Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Proteins|June 12, 2023
New prediction categories in CASP15Andriy Kryshtafovych, Maciej Antczak, Marta Szachniuk, et al.
European Journal of Neurology|February 13, 2023
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosisArabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2025
White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse ActivityMario Ocampo-Pineda, Alessandro Cagol, Pascal Benkert, et al.
Critical Care (London, England)|January 21, 2021
Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective studySabina Hunziker, Adrian Quinto, Maja Ramin-Wright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosisTomas Uher, Eva Kubala Havrdova, Pascal Benkert, et al.
Journal of Cardiac Failure|November 19, 2013
Heart failure therapy-induced early ST2 changes may offer long-term therapy guidanceTobias Breidthardt, Cathrin Balmelli, Raphael Twerenbold, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 30, 2023
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomesMelissa Amrein, Stephanie Meier, Ibrahim Schäfer, et al.
Therapeutic Advances in Neurological Disorders|July 22, 2025
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGADPatrick Schindler, Ulrike Grittner, Rebekka Rust, et al.
Clinical Chemistry and Laboratory Medicine|December 17, 2025
Comparative analysis of three platforms for serum NfL quantification in healthy controls and MS patientsJustina Dargvainiene, Antje Torge, Klaus-Peter Wandinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2022
High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosisMartin Diebold, Edoardo Galli, Andreas Kopf, et al.
Pageof 25